These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 30460897)

  • 21. Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota.
    Jess T; Loftus EV; Velayos FS; Harmsen WS; Zinsmeister AR; Smyrk TC; Tremaine WJ; Melton LJ; Munkholm P; Sandborn WJ
    Inflamm Bowel Dis; 2006 Aug; 12(8):669-76. PubMed ID: 16917220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adherence to guidelines for surveillance colonoscopy in patients with ulcerative colitis at a Canadian quaternary care hospital.
    Kottachchi D; Yung D; Marshall JK
    Can J Gastroenterol; 2009 Sep; 23(9):613-7. PubMed ID: 19816624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term Risk of Advanced Neoplasia After Colonic Low-grade Dysplasia in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study.
    De Jong ME; Van Tilburg SB; Nissen LHC; Kievit W; Nagtegaal ID; Horjus CS; Römkens TEH; Drenth JPH; Hoentjen F; Derikx LAAP
    J Crohns Colitis; 2019 Dec; 13(12):1485-1491. PubMed ID: 31175827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated Overview.
    Choi CH; Rutter MD; Askari A; Lee GH; Warusavitarne J; Moorghen M; Thomas-Gibson S; Saunders BP; Graham TA; Hart AL
    Am J Gastroenterol; 2015 Jul; 110(7):1022-34. PubMed ID: 25823771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis.
    Rozen P; Baratz M; Fefer F; Gilat T
    Gastroenterology; 1995 May; 108(5):1361-70. PubMed ID: 7729627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ulcerative colitis-associated colorectal cancer.
    Yashiro M
    World J Gastroenterol; 2014 Nov; 20(44):16389-97. PubMed ID: 25469007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pilot study on the endoscopic surveillance of colorectal dysplasia and cancer in long-standing ulcerative colitis.
    Khorrami Mashhadi S; Trapero M; Gisbert JP; Gómez Domínguez E; Maté Jiménez J
    Rev Esp Enferm Dig; 2005 Jan; 97(1):16-23. PubMed ID: 15801894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology and risk factors for colorectal dysplasia and cancer in ulcerative colitis.
    Loftus EV
    Gastroenterol Clin North Am; 2006 Sep; 35(3):517-31. PubMed ID: 16952738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased Active Inflammation in the Colon is Not a Reliable Predictor of an Elevated Risk of Dysplasia in Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis.
    Zhang R; Wang D; Lauwers GY; Choi WT
    Am J Surg Pathol; 2024 Sep; 48(9):1154-1163. PubMed ID: 38809303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysplastic Progression to Adenocarcinoma is Equivalent in Ulcerative Colitis and Crohn's Disease.
    Lightner AL; Vogler S; McMichael J; Jia X; Regueiro M; Qazi T; Steele SR
    J Crohns Colitis; 2021 Jan; 15(1):24-34. PubMed ID: 32592468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
    Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
    J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylated eyes absent 4 (EYA4) gene promotor in non-neoplastic mucosa of ulcerative colitis patients with colorectal cancer: evidence for a field effect.
    Kisiel JB; Garrity-Park MM; Taylor WR; Smyrk TC; Ahlquist DA
    Inflamm Bowel Dis; 2013 Sep; 19(10):2079-83. PubMed ID: 23867875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients with Endoscopically Visible Polypoid Adenomatous Lesions Within the Extent of Ulcerative Colitis Have an Increased Risk of Colorectal Cancer Despite Endoscopic Resection.
    Subramanian V; Chatu S; Echterdiek F; Banerjee A; Finlayson C; Pollok RCG
    Dig Dis Sci; 2016 Oct; 61(10):3031-3036. PubMed ID: 27405991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease.
    Eluri S; Parian AM; Limketkai BN; Ha CY; Brant SR; Dudley-Brown S; Efron JE; Fang SG; Gearhart SL; Marohn MR; Meltzer SJ; Bashar S; Truta B; Montgomery EA; Lazarev MG
    Dig Dis Sci; 2017 Dec; 62(12):3586-3593. PubMed ID: 28631086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
    Tung BY; Emond MJ; Haggitt RC; Bronner MP; Kimmey MB; Kowdley KV; Brentnall TA
    Ann Intern Med; 2001 Jan; 134(2):89-95. PubMed ID: 11177311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease.
    Shah SC; Glass J; Giustino G; Hove JRT; Castaneda D; Torres J; Kumar A; Elman J; Ullman TA; Itzkowitz SH
    Gut Liver; 2019 Jan; 13(1):54-61. PubMed ID: 30400722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis and the risk of developing malignancies. A large prospective study.
    Terg R; Sambuelli A; Coronel E; Mazzuco J; Cartier M; Negreira S; Muñoz A; Gil A; Miguez C; Huernos S; Romero G; Goncalvez S; Levi D; Abecasis R
    Acta Gastroenterol Latinoam; 2008 Mar; 38(1):26-33. PubMed ID: 18533354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carcinogenesis in inflammatory bowel disease.
    Herszenyi L; Miheller P; Tulassay Z
    Dig Dis; 2007; 25(3):267-9. PubMed ID: 17827953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory bowel disease as a risk factor for colorectal cancer.
    Lukas M
    Dig Dis; 2010; 28(4-5):619-624. PubMed ID: 21088413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Anti-tumour Necrosis Factor Agents on the Risk of Colorectal Cancer in Patients with Ulcerative Colitis: Nationwide French Cohort Study.
    Charkaoui M; Hajage D; Tubach F; Beaugerie L; Kirchgesner J
    J Crohns Colitis; 2022 Jul; 16(6):893-899. PubMed ID: 34657962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.